Daniel identified a lack of constructive communication between big pharma and health care companies, initially inspiring him to develop F1000, a platform that powers professional conversation and discussion between researchers. At Health 2.0 London, Daniel demoed why F1000 is considered one of the biggest open source publication sites and it’s latest functionality which allows for researchers across a number of teams to share, tag, and analyze information.
Health 2.0 companies have brought in much needed tools to make navigating the Pharma industry easier. With complex databases allowing users greater transparency of drug costs and interactions, as well as new tools for increasing adherence, the world of Pharma is becoming increasingly more user friendly for both patients and doctors alike. Marc Southern of FleishmanHillard presented their research on authenticity and consumer expectation in Pharma followed by 5 companies doing work in Pharmaceutical media, tracking, adherence and more.
buzzimi officially launched their meeting platform “Engage” on stage at Health 2.0 Europe this November, debuting their meeting platform that bridges the information gap between web analytics and physical pharma sales meetings. buzzumi sees extensive opportunity for enhancing pharma sales by creating a platform that monitors and tracks the sale process between pharma and physician.